Problem: Ureaplasma species occasionally cause chorioamnionitis and premature labor. We developed a novel assay employing a loop-mediated isothermal amplification (LAMP) method to detect Ureaplasma parvum and Ureaplasma urealyticum.
| INTRODUCTION
Chorioamnionitis (CAM) is one of the most important causes of premature labor. [1] [2] [3] [4] In addition to standard treatments, such as bed rest and β2 stimulants and/or magnesium sulfates, antibiotics are administered if CAM is suspected. However, frequently prescribed β-lactam antibiotics, such as penicillins and cephalosporins, are not effective against bacteria that lack cell walls. Routine use of β-lactam can also exacerbate Mycoplasma infection.
Ureaplasma species are frequently isolated from the amniotic fluid and placentae of women who deliver preterm babies. 5 Based on their presumed pathological roles, macrolide antibiotics are often administered to patients undergoing premature labor with a diagnosis of occult CAM, because macrolide antibiotics possess broad antibacterial spectrum and they are safe for pregnant women. However, the routine use of these antibiotics is not recommended due to the increased frequency of macrolide-resistant bacterial pathogens. 6 Ureaplasma spp. are the smallest bacteria and are often isolated from human genital mucosa of individuals with a lack of symptoms.
In humans, two major species, namely Ureaplasma parvum (U. parvum)
and Ureaplasma urealyticum (U. urealyticum), are important.
7
These bacteria cause inflammation and lead to CAM, preterm deliveries, and premature rupture of membranes. 1, 8 Recently, their pathogenic roles on spermatogenesis and subsequent male infertility have been also suggested. 9, 10 Although both male and female carriers are asymptomatic, Ureaplasma spp. is occasionally isolated from the neonatal lesions of bronchopulmonary dysplasia, intraventricular hemorrhage, and necrotizing enterocolitis. [11] [12] [13] For appropriate use of antibiotics, rapid and accurate diagnosis of Ureaplasma spp. is needed but is currently unavailable. Culturing, the gold standard method, requires special media, a culture chamber and at least 2-3 days. 13 Molecular diagnosis employing PCR can be an important alternative but it also requires 3 hours for the purification and amplification of DNA. In addition, PCR requires thermal cyclers, electrophoresis chambers, and DNA sequencers.
The loop-mediated isothermal amplification (LAMP) method is an alternative nucleic acid detection method that utilizes a unique priming mechanism, and the specific DNA products are amplified under isothermal conditions. The LAMP-amplified products can be recognized by observation of reaction tubes, and thus, this method does not require thermal cycling and electrophoresis. These advantages could enable bedside use of LAMP for the detection of Ureaplasma spp. In this study, we developed a novel LAMP system for the first time and demonstrated its superiority over conventional culture and PCR.
| MATERIALS AND METHODS

| Bacterial strains
To assess the sensitivity and specificity of LAMP detection, we evaluated 9 Ureaplasma strains and 14 non-Ureaplasma species. The sources of these genomes are shown in Table 1 Streptococcus salivarius (ATCC 7073). The 9 Ureaplasma species were four U. parvum strains (SV3F4, B7, S55, and OMC-P162) and five U. urealyticum strains (F7, F24, S18, S59, and S100).
| Preparation of template DNA
Genomic DNA was purified from the 23 samples above using a To determine DNA copy numbers, first the concentration of obtained gene fragments was determined using a Nanodrop 1000 (Thermo Fisher Scientific). Then, standard copy numbers were calculated based on the expected fragment genes (each of the PCR products plus pCR-TOPO pUC57, 4691 bp for U. parvum, and 4692 bp for U. urealyticum).
| Primer design for Ureaplasma parvum and
Ureaplasma urealyticum
Two LAMP primer sets, including two loop primers (loop primer forward, LF; and loop primer backward, LB), were designed using Primer Explorer V5 (https://primerexplorer.jp/lampv5/index.html) ( Table 2 ; Figure 1 ). The target genes were ureaseB from U. parvum (GenBank accession no. AF085732.1) and ureaseB from U. urealyticum (GenBank accession no. AF085726.2), which were well conserved in each biovar. PCR primers for the detection of U. parvum and U. urealyticum were taken from a published article (Table 3 ).
14 All primers were synthesized by Hokkaido System Science (Sapporo, Hokkaido, Japan).
| LAMP reaction for Ureaplasma parvum and Ureaplasma urealyticum
Loop-mediated isothermal amplification reactions were performed in 
| PCR analysis of Ureaplasma parvum and Ureaplasma urealyticum
PCRs were performed in a 25-μL volume consisting of 5 μL template, 0.5 U of TaKaRa Ex Taq, 0.2 mmol/L deoxynucleotide mixture, and 10× TaKaRa Ex Taq Buffer. For the U. parvum assay, 0.8 μmol/L each of primers UPF and UPR was used, whereas for the U. urealyticum assay, 0.8 μmol/L each of primers UUF and UUR was used.
14 Amplification conditions were set with an initial denaturation step for 1 minute followed by 30 cycles consisting of 94°C for 30 seconds, 55°C for 30 seconds, and 72°C for 1 minute with a final extension step at 72°C for 15 minutes. Positive (U. parvum DNA or U. urealyticum DNA) and negative (nuclease-free water) controls were included.
The PCR products were analyzed using a microchip electrophoresis system (MCE-202 MultiNA; SHIMADZU, Kyoto, Japan).
| Analysis of LAMP products
Ureaplasma parvum and U. urealyticum LAMP products were verified by direct sequencing using a BigDye ® Terminator V3.1 cycle sequencing kit (Applied Biosystems, Foster City, CA, USA) and a 3130xL Genetic Analyzer (Applied Biosystems). The following primer sets were used to sequence the target regions: U. parvum F2, 5ʹ-GCAATTAATTTCGCTAGTGGTG-3ʹ and U. parvum B2, 5ʹ-GCGTTCTTTATCTTCATTTCCTT-3ʹ; and U. urealyticum F2, 5ʹ-ATTAACTTCGCTGAAGGCG-3ʹ and U. urealyticum B2, 5ʹ-CGTTCTTTGTCTTCGTTTCC-3ʹ.
| Clinical specimens
In total, 46 specimens were collected from Hirata clinic (Kumagaya, T The colonies of Ureaplasma spp. were collected by an inoculating loop and transferred into a 1.5-mL tube with 1 mL phosphate-buffered saline (PBS). After centrifugation, the supernatant was discarded, and the remaining 50 μL was used for DNA extraction by the Loopamp SR DNA extraction kit (Eiken Co., Ltd). Then, the extracted DNA samples were used as the templates for PCR and LAMP assays.
| Statistical analysis
The clinical sensitivity, specificity, positive predictive values (PPV), and negative predictive values (NPV) of the LAMP and PCR assays were compared to those of the conventional culture method. The gold standard was the results from the conventional culture method. The 95% confidential interval (CI) was calculated using standard interval estimation and Jeffreys prior interval for a small n, as previously described. 16 
| RESULTS
| Analytical reactivity and specificity
P. mirabilis, and S. salivarius).
For each assay mixture, a standard concentration of genomic DNA (10 6 copies) was used for each sample.
Four U. parvum strains (SV3F4, B7, S55, and OMC-P162) were examined using the U. parvum LAMP assay. Every sample showed positive results within 30 minutes, whereas non-U. parvum samples showed negative results after 60 minutes of incubation. We observed similar results in the U. urealyticum samples. All of the 5 U. urealyticum strains (F24, F7, S18, S59, and S100) were positive, whereas all of the non-U. urealyticum samples were negative.
Loop-mediated isothermal amplification-amplified products were 
| Detection limit
Serial 10-fold dilutions of ureaseB gene fragments from the U. parvum and U. urealyticum strains were reliably amplified at the lowest limit of 100 genome copies per reaction (Figures 2 and 3) . In contrast, two conventional PCR assays targeting U. parvum and U. urealyticum had a detection limit of 10 4 copies per reaction (Figures 4 and 5) . Our results suggest 100 times higher sensitivity of the LAMP method compared with single-round PCR. The detection limits of the LAMP assays were identical to those obtained using real-time turbidimetry and naked eye visual inspection. Experiments were performed at least twice on different days. 
| Analysis of clinical specimens
| DISCUSSION
Ureaplasma infection is a major concern in perinatal medicine because it can cause pregnancy complications, including premature labor and/or neonatal inflammatory disorders. 1, 8, [11] [12] [13] 17 Early detection of F I G U R E 2 Detection limit of loopmediated isothermal amplification targeting the Ureaplasma parvum ureaseB gene. Using serial dilutions of cloned DNA, sensitivity of loop-mediated isothermal amplification reaction was assessed by visual observation of turbidity. The detection limit was 10 2 copies/reaction F I G U R E 3 Detection limit of loopmediated isothermal amplification (LAMP) targeting the Ureaplasma urealyticum ureaseB gene. Using serial dilutions of cloned DNA, sensitivity of LAMP reaction was assessed by visual observation of turbidity. The detection limit was 10 2 copies/reaction
Ureaplasma infection in female genital tracts enables appropriate use of antibiotics. However, conventional culture and PCR are limited due to time-consuming procedures and technical difficulties.
In this study, we developed a novel LAMP detection method for the first time and examined its specificity, sensitivity, and possibilities for clinical application using freshly prepared human vaginal discharge samples.
Many publications have shown the importance of using the culture method to detect Ureaplasma infection in obstetric and neonatal samples. 15, 18 Culture is still the gold standard for the detection Another limitation of our study is the small sample size that was collected from a single institution. The sampling and transportation conditions are critical in the detection of Ureaplasma because the bacteria are reported to be susceptible to temperature changes. 13, 18 However, we believe that DNA detection methods, such as PCR and LAMP, show improved sensitivity because we can detect "dead" bacteria that are not detectable by culture. In addition, we designated singletube transfer and nucleic acid purification to avoid contaminations.
By their polymorphic natures, Mycoplasmaceae including Ureaplasma spp. often contaminate into cell and bacterial cultures. Thus, we can minimize environmental contamination and/or tube-to-tube contamination by our method.
In future studies, this strategy must be examined in multicenter analyses and assessed for the therapeutic effects of antibiotics on patients with Ureaplasma infection.
In summary, we established a simple and sensitive method for the detection of Ureaplasma spp., and we believe it can enable early detection of the infection in pregnant women and appropriate administration of antibiotics.
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